Other Hematopoietic
Showing 1 - 25 of >10,000
Severe Aplastic Anemia, MDS (Myelodysplastic Syndrome) Trial in Baltimore, Bethesda, Minneapolis (Miltenyi CD34 Reagent System,
Recruiting
- Severe Aplastic Anemia
- MDS (Myelodysplastic Syndrome)
- Miltenyi CD34 Reagent System
- Donor derived G-CSF mobilized PBC
-
Baltimore, Maryland
- +2 more
Jan 25, 2023
Other Cancer Trial in Boston (Mobile App + enhanced standard care, Enhanced Standard Care)
Active, not recruiting
- Other Cancer
- Mobile App + enhanced standard care
- Enhanced Standard Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 24, 2023
Other Cancer Trial in United States (Shared Care, Standard Care)
Completed
- Other Cancer
- Shared Care
- Standard Care
-
Stamford, Connecticut
- +8 more
Nov 1, 2022
CIBMTR Research Database
Recruiting
- Autologous Stem Cell Transplantation
- +6 more
-
Minneapolis, Minnesota
- +1 more
Jan 20, 2023
Pediatric Patients, Hematologic Malignancy, Other Hematologic Condition Trial in Aurora (CliniMACS Plus Instrument)
Not yet recruiting
- Pediatric Patients
- +2 more
- CliniMACS Plus Instrument
-
Aurora, ColoradoChildren's Hospital Colorado
Jun 29, 2022
Other Cancer Trial in Boston (ruxolitinib)
Recruiting
- Other Cancer
-
Boston, MassachusettsMassachusetts General Hospital
Sep 30, 2021
Research Sample Repository for Hematopoietic Cell
Recruiting
- Autologous Stem Cell Transplantation
- +3 more
-
New Brighton, MinnesotaNMDP Biorepository
Jun 3, 2021
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Taselisib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Feb 4, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Crizotinib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Feb 4, 2022
Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow
Available
- Benign Neoplasm
- +3 more
- Bone Marrow Transplantation
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 9, 2021
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Columbus (Health Promotion and Education, Medical
Active, not recruiting
- Acute Lymphoblastic Leukemia
- +11 more
- Health Promotion and Education
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jul 24, 2023
Hematopoietic Cell Transplantation (HCT) Trial (Tributyrin)
Not yet recruiting
- Hematopoietic Cell Transplantation (HCT)
- Tributyrin
- (no location specified)
Jul 11, 2023
Lymphoma, Multiple Myeloma Trial in Chongqing (pegylated recombinant human granulocyte-colony stimulating factor)
Recruiting
- Lymphoma
- Multiple Myeloma
- pegylated recombinant human granulocyte-colony stimulating factor
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Sep 23, 2023
Factors Impeding Physical Activity During Post-discharge Period
Not yet recruiting
- Physical Activities
- interview
- (no location specified)
Oct 24, 2023
BK Virus Disease After Allogeneic Hematopoietic-cell
Active, not recruiting
- BK Virus Infection
- Symptom index questionnaire
- +2 more
-
Boston, MassachusettsDana-Farber Cancer Institute
Jan 27, 2023
GATA2, Immunodeficiency Trial run by the National Cancer Institute (NCI) (drug, radiation, procedure)
Not yet recruiting
- GATA2
- Immunodeficiency
- Mycophenolate Mofetil
- +7 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jun 23, 2023
Medulloblastoma, CNS Embryonal Tumors Trial in Canada, New Zealand, United States (Induction, Single Cycle Intensive
Recruiting
- Medulloblastoma
- Central Nervous System Embryonal Tumors
- Induction
- +2 more
-
Birmingham, Alabama
- +61 more
Feb 16, 2022
MDS Trial in Seoul (cyclophosphamide, fludarabine, and antithymocyte globulin)
Active, not recruiting
- Myelodysplastic Syndromes
- cyclophosphamide, fludarabine, and antithymocyte globulin
-
Seoul, Korea, Republic ofAsan Medical Center, University of Ulsan College of Medicine
Oct 19, 2023
HIV, Lymphoma Trial in Zhanjiang (KL-7SHRNA injection solution)
Recruiting
- HIV Infections
- Lymphoma
- KL-7SHRNA injection solution
-
Zhanjiang, Guangdong, ChinaAffiliated hospital of Guangdong medical university
Jun 24, 2023
Haplo-HSCT for Elderly Acute Leukemia/ Myelodysplastic Syndrome
Not yet recruiting
- Acute Leukemia
- Myelodysplastic Syndromes
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jun 5, 2023
Blood Cancer, Refractory Immune Cytopenias Trial in United States (Isatuximab)
Not yet recruiting
- Blood Cancer
- Refractory Immune Cytopenias
- Isatuximab
-
Basking Ridge, New Jersey
- +6 more
May 15, 2023
Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and
Recruiting
- Granuloma
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Hepatitis B Reactivation, Hematopoietic Stem Cell Transplantation, Antiviral Drug Trial in Seoul (Entecavir)
Enrolling by invitation
- Hepatitis B Reactivation
- +3 more
-
Seoul, Korea, Republic ofJeong Won Jang
Dec 16, 2022
Hematopoietic Tumors, Hematopoietic Malignancy Trial in Boston (STEPP Intervention, Usual Care)
Not yet recruiting
- Hematopoietic Neoplasms
- Hematopoietic Malignancy
- STEPP Intervention
- Usual Care
-
Boston, Massachusetts
- +1 more
Aug 30, 2023
Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, MDS Trial in Houston (CliniMACS)
Not yet recruiting
- Acute Lymphoblastic Leukemia in Remission
- +10 more
- CliniMACS
-
Houston, Texas
- +1 more
Dec 8, 2022